Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, ...
Shares of Carisma Therapeutics Inc. (CARM) have been struggling lately and have lost 12.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...
Carisma Therapeutics Inc. Annual stock financials by MarketWatch. View the latest CARM financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results